DOTTIKON ES: Partial sale with a whopping +63% profit!

The stock market, which is repeatedly characterized by setbacks, has prompted us to make partial sales of the shares of DOTTIKON ES, a contract manufacturer for pharmaceutical and chemical active ingredients. Our purchase price stands at a low CHF 202.86. Having already realized a partial sale on 12 June with a profit of +42.3%, we succeeded in selling a further tranche on 24 October at an increased price target of CHF 330; the profit: an outstanding +62.7%! Nevertheless, our optimism remains unbroken. DOTTIKON ES produces high-purity fine chemicals that are mainly used in the pharmaceutical industry... and medicines are always needed, regardless of whether there is a recession, war or inflation. This protects DOTTIKON ES from economic fluctuations, as sales remain stable. In addition, DOTTIKON ES operates with high profit margins and without debt - which would be an advantage in times of rising interest rates. Many companies are currently struggling with expensive loans, but DOTTIKON ES is sitting on a high level of cash and is constantly investing in the expansion of production from its own resources. CEO Markus Blocher (son of Christoph Blocher) has a reputation as a disciplined entrepreneur who thinks long-term. He communicates conservatively, consistently delivers solid figures and does not allow short-term "games". Many investors see DOTTIKON ES as a "safe haven" in uncertain times. While a number of industries fluctuate in the cycle, DOTTIKON ES is growing continuously because demand for active pharmaceutical ingredients and production capacities in Europe is increasing (also due to supply chain risks in China). Many pharmaceutical companies are relocating back to Europe, and DOTTIKON ES is benefiting from this. The company produces exclusively in Switzerland!

The potential of the DOTTIKON ES share is probably far from exhausted. We are therefore setting a new price target of CHF 385 for the remaining tranche! We will use price setbacks - in almost every case - to add to the position!

The Swiss stock market letter WIRTSCHAFTSINFORMATION

  • Every 14 days 10-12 pages of stock market tips for shares, precious metals and commodities
  • Profit, risk assessment per stock recommendation
  • Editorial with market assessment
  • Actively managed sample portfolio
  • Stock market tips + stock recommendations formulated in an understandable way
  • Advertising-free, independent and objective To thereading sample

Test the free subscription now without obligation